(Q59489199)
Statements
A phase 2a, randomized, double-blind 28-day study of TZP-102 a ghrelin receptor agonist for diabetic gastroparesis (English)
N Ejskjaer
J M Wo
T Esfandyari
M Mazen Jamal
G Dimcevski
E Mondou
J Quinn
F Rousseau
23 December 2012